UCSF

GHB use down overall

Reports to the California Poison Control System of the use of the drug gamma hydroxybutate (GHB) have declined overall from 1999 to 2003. These findings were reported on December 29, 2005 in the Annals of Emergency Medicine. The lead study author is Ilene Anderson, PharmD, UCSF School of Pharmacy faculty member and clinical pharmacist with the California Poison Control System, which is administered by the UCSF School of Pharmacy.

Tags

Category:
Sites:
School of Pharmacy, PharmD Degree Program

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.